An online resource for the extracellular matrix and tissue engineering research community. Part of the @STEMCELLTech Science News service.

Joined June 2010
3,022 Photos and videos
GIVEAWAY! πŸ˜πŸŽ‰ Don't miss your chance to win a pair of @STEMCELLTech science socks! 🧦 To enter, sign up to receive the latest research highlights in your field delivered to your inbox with STEMCELL Science News. πŸ’Œ πŸ”— Learn more: bit.ly/4sFyUzh
1
143
πŸ“’ Exciting news! @MannKindCorp has advanced its inhaled nintedanib therapy for idiopathic #PulmonaryFibrosis into Phase 2 clinical testing, aiming to improve tolerability and lung-targeted drug delivery compared with the current oral treatment. Learn more: bit.ly/4xrv9jE
1
168
New work shows that ZNF469 drives lung fibroblast activation and collagen production downstream of TGF-Ξ²1/SMAD3 signaling, making it a potential therapeutic target for #PulmonaryFibrosis. πŸ—’οΈ Read the @bjbms study: bit.ly/43rXWXK
194
πŸ“’ New in @ScienceAdvances! Researchers led by Drs. Karen Oegema and Arshad Desai (@oegemadesai_lab) at @UCSanDiego have uncovered a multistep mechanism by which PLK1 #phosphorylation activates centrosomal protein SPD-5 to recruit Ξ³-tubulin complexes and precisely control #microtubule nucleation during mitotic spindle assembly. Learn more: bit.ly/4ebxgzj
199
Researchers have developed a matrix metalloproteinase-responsive #hydrogel system that delivers RANKL inhibitors directly to fibrous #dysplasia lesions, reducing disease progression while minimizing systemic drug exposure. πŸ”¬ Learn more: bit.ly/4vypy9s
1
2
172
This review frames stress urinary incontinence as a clinically relevant ECM-failure niche and synthesizes ECM-targeted biomaterials and nanocarriers designed to rebalance the MMP/TIMP axis while enabling pragmatic pharmacodynamic readouts for early translation. πŸ“– bit.ly/43vdn1z
1
2
195
In this study, researchers investigated the role of mesangial cell–derived ECM protein 1 in regulating mesangial matrix homeostasis and glomerular structure in mice. πŸ”¬ bit.ly/436nGsF
1
5
320
To modulate the oxidative microenvironment and remodel the ECM, a smart microneedle capable of regulating reactive oxygen species and delivering matrix metalloproteinase functions was developed. πŸ’‰ @acsnano | bit.ly/4dmgkaq
3
268
🧫 The central mechanotransduction mechanisms through which matrix stiffness drives fibrotic progression remain poorly understood. To investigate this, primary human corneal fibroblasts were cultured on hydrogels with varying stiffness. @ActaBio | bit.ly/4veXwQq
9
529
🦴 The development of artificial scaffolds capable of providing dynamically evolving mineralized niches for MSCs remains challenging. That's why scientists developed hierarchical graphene-doped PMMA scaffolds and demonstrated its potential for regenerating critical-sized bone defects. @Biomaterials_ | bit.ly/4dYvrWD
183
Oorja Bio has reported promising Phase 1 and preclinical results for ORJ-001, a first-in-class peptide therapy for idiopathic #PulmonaryFibrosis that restores alveolar epithelial cell function and is advancing to Phase 2 trials. πŸ’Š Press release: bit.ly/3Q9TM3G
1
189
A new study from researchers in China has identified a #hypoxia-driven stromal niche in #HepatocellularCarcinoma where ADAM8⁺ macrophages and FAP⁺ fibroblasts promote extracellular matrix remodeling and are associated with poor patient outcomes. πŸ”¬ Read the @CIR_AACR study: bit.ly/4uCozoN
2
193
Using a patient-derived fibrotic tumor model, researchers show that stromal stiffness drives chemoresistance through YAP signaling rather than drug penetration barriers, enabling an effective sequential therapy strategy to restore #chemotherapy sensitivity. πŸ”¬ Learn more: bit.ly/4dukzkl
1
269
This new @ACSPublications #review highlights the potential of self-assembling extracellular matrix-mimetic #peptides as customizable, low-immunogenic scaffolds for tissue engineering, regenerative medicine, and drug delivery applications. Learn more: bit.ly/3RxXnZN
1
3
331
Join @NYASciences on June 9, 2026, for Molecular Pathways & Cellular Players in the Resolution of Organ Fibrosis - a one-day symposium exploring cellular players, multiomics insights, & new therapeutic directions in fibrosis research. Register: bit.ly/4jS7FxQ
3
255
The authors at @NCState investigated myocardial dECM-based fibrous scaffolds for iPSC-derived cardiomyocyte use Coaxially electrospun nanofibers comprising a polyurethane core and a blend of polycaprolactone and myocardial dECM as the sheath were optimized. πŸ‘‰ bit.ly/4wYDhbs
1
3
330
πŸ’“ This study defines diabetic cardiomyopathy by the concurrent dysregulation of cardiac fuel metabolism, mitochondrial quality control, and matrix remodeling, highlighting ACSL1 and BNIP3L as therapeutic targets for diabetes-associated cardiac dysfunction. @GenomeMedicine | bit.ly/4nFcxIx
1
213
Investigators provided a clinically relevant framework for material design and established a closed-loop therapeutic strategy that integrates pathological signal decoding with targeted intervention, offering a approach for pathological scar treatment. @acsnano | bit.ly/4dmgkaq
3
291
This review examines the evolving understanding of #fibroblast biology in the context of myocardial fibrosis, emphasizing their contributions to inflammation and extracellular matrix dysregulation and their interactions with cardiomyocytes and endothelial cells. πŸ”— bit.ly/4nAKbPG
1
230
πŸ‘‡ Check this out! Researchers identified LRRC15 cancer-associated #fibroblasts (CAFs) as a tumor-specific CAF subset in lung cancer and proposed LRRC15 as a potential therapeutic target. @CR_AACR | bit.ly/4uP6Biz
1
286
A new @CR_AACR study from researchers at Peking University identifies LRRC15 cancer-associated #fibroblasts as a tumor-promoting cell population in #LungCancer and highlights it as a promising therapeutic target to enhance anti-tumor immunity. 🧾 Read the study: bit.ly/4uP6Biz
2
224